GIC
ABBV icon

Generali Investments CEE’s AbbVie ABBV Stock Holding History

Generali Investments CEE’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.97M Sell
35,651
-983
-3% -$211K 0.43% 66
2026
Q1 		$7.97M Sell
36,634
-1,404
-4% -$311K 0.42% 69
2025
Q4 		$8.69M Hold
38,038
– – 0.61% 40
2025
Q3 		$8.81M Sell
38,038
-476
-1% -$96.9K 0.67% 37
2025
Q2 		$7.15M Buy
38,514
+655
+2% +$122K 0.59% 42
2025
Q1 		$7.93M Sell
37,859
-1,691
-4% -$329K 0.74% 30
2024
Q4 		$7.03M Buy
+39,550
New +$7.27M 0.72% 36

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Generali Investments CEE's ABBV Position: Q2 2026 in Review

Generali Investments CEE reduced its AbbVie (ABBV) stake by 2.7% in Q2 2026, selling an estimated $211K and leaving 35,651 shares worth $8.97M. The position accounts for 0.43% of the portfolio, ranked #66.

Generali Investments CEE first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Generali Investments CEE held 35,651 shares of AbbVie worth $8.97M as of Q2 2026.
  • Generali Investments CEE sold 983 AbbVie shares in Q2 2026, an estimated $211K.
  • AbbVie made up 0.43% of Generali Investments CEE's portfolio in Q2 2026, its #66 holding.
  • Generali Investments CEE first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.